BioScrip Inc. has received shareholder approval of its proposed merger with fellow healthcare provider Option Care Enterprises Inc. at an Aug. 2 stockholder meeting.
The all-stock deal, announced in March, is on track to close Aug. 6, Denver-based BioScrip said in a press release.
The transaction, which will allow the combined company to cover 96% of the U.S. population with its home and alternate site infusion services, has already received U.S. antitrust clearance.
